XW020D8 ICD-10-PCS Code: Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8
Introduce Enginr Allo Thym Tiss in Muscle, Open, New Tech 8
Axis Breakdown
Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.
| Position | Value | Meaning |
|---|---|---|
| 1 | SectionX | New Technology |
| 2 | Body SystemW | Anatomical Regions |
| 3 | Root Operation0 | Introduction Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products |
| 4 | Body Part2 | Muscle |
| 5 | Approach0 | Open |
| 6 | Device / Substance / TechnologyD | Engineered Allogeneic Thymus Tissue |
| 7 | New Technology Group8 | New Technology Group 8 |
MS-DRG Grouper Relationships (FY2026)
Potential MS-DRG participation — not a DRG assignment.
The MS-DRG grouper treats this as an operating room procedure. It appears in the surgical logic of 3 MS-DRGs:
From the CMS MS-DRG Definitions Manual, Appendix E. Actual DRG assignment depends on the complete claim.
Related Codes
Same procedure category (CCSR), other tables
AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration and transfusion of bone marrow, stem cells, pancreatic islet cells, and t-cells (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.
3E0Q0E1 — Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach, 3E0Q3AZ — Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach, 3E0Q3E0 — Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach, 3E0Q3E1 — Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach, 3E0R0AZ — Introduction of Embryonic Stem Cells into Spinal Canal, Open Approach, 3E0R0E0 — Introduction of Autologous Somatic Stem Cells into Spinal Canal, Open Approach, 3E0R0E1 — Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Open Approach, 3E0R3AZ — Introduction of Embryonic Stem Cells into Spinal Canal, Percutaneous Approach, 3E0R3E0 — Introduction of Autologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach, 3E0R3E1 — Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach, XW1337A — Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW133B8 — Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133C8 — Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133F8 — Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133G8 — Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133H9 — Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9, XW133J8 — Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133SB — Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11, XW1437A — Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10, XW143B8 — Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8, +50 more
Contextual Map
Every relationship of XW020D8 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Run XW020D8 with these 5 related codes in Claim Check
PCS table
- XW0[PCS table]— CMS ICD-10-PCS tables
- New Technology — Section: New Technology[Section]: “New Technology”— CMS ICD-10-PCS tables
- Anatomical Regions — Body System: Anatomical Regions[Body System]: “Anatomical Regions”— CMS ICD-10-PCS tables
- Introduction — Operation: Introduction[Operation]: “Introduction”— CMS ICD-10-PCS tables
MS-DRG participation
- DRG 628 — OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH MCC[MS-DRG]: “OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH MCC — Other Endocrine, Nutritional and Metabolic O.R. Procedures (MDC 10)”— CMS MS-DRG Definitions Manual (Appendix E) · FY2026
- DRG 629 — OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH CC[MS-DRG]: “OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH CC — Other Endocrine, Nutritional and Metabolic O.R. Procedures (MDC 10)”— CMS MS-DRG Definitions Manual (Appendix E) · FY2026
- DRG 630 — OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITHOUT CC/MCC[MS-DRG]: “OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITHOUT CC/MCC — Other Endocrine, Nutritional and Metabolic O.R. Procedures (MDC 10)”— CMS MS-DRG Definitions Manual (Appendix E) · FY2026
Clinical classification (CCSR)
- ADM011 — Administration and transfusion of bone marrow, stem cells, pancreatic islet cells, and t-cells[CCSR category]: “Administration and transfusion of bone marrow, stem cells, pancreatic islet cells, and t-cells — Administration of Therapeutic Substances”— AHRQ CCSR for ICD-10-PCS Procedures (HCUP) · v2026.1
MDC crossing · diagnoses (633)
- MDC 10 — Endocrine, Nutritional and Metabolic Diseases and Disorders[MDC crossing]: “Endocrine, Nutritional and Metabolic Diseases and Disorders — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs.”— CMS MS-DRG Definitions Manual · FY2026
- A18.7 — Tuberculosis of adrenal glands[Same-MDC diagnosis]: “Tuberculosis of adrenal glands — grouped in MDC 10, the diagnosis side of this code's crossing.”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
- A18.81 — Tuberculosis of thyroid gland[Same-MDC diagnosis]: “Tuberculosis of thyroid gland — grouped in MDC 10, the diagnosis side of this code's crossing.”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
- B67.31 — Echinococcus granulosus infection, thyroid gland[Same-MDC diagnosis]: “Echinococcus granulosus infection, thyroid gland — grouped in MDC 10, the diagnosis side of this code's crossing.”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
- C73 — Malignant neoplasm of thyroid gland[Same-MDC diagnosis]: “Malignant neoplasm of thyroid gland — grouped in MDC 10, the diagnosis side of this code's crossing.”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
- C74.00 — Malignant neoplasm of cortex of unspecified adrenal gland[Same-MDC diagnosis]: “Malignant neoplasm of cortex of unspecified adrenal gland — grouped in MDC 10, the diagnosis side of this code's crossing.”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
- and 628 more
Change history
No changes recorded for this code. This ledger tracks additions, deletions and description changes from FY2026 (April) onward. Note changes are not tracked.
Read from: CMS ICD-10-PCS code tables, index and definitions — FY2026 (April); CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v43; AHRQ HCUP Clinical Classifications Software Refined for ICD-10-PCS Procedures (hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR_v2026-1.zip) — v2026.1. All data sources · How to read the labels